9Rondon C, Dona I, Tortes M J, et al. Evolution of patients with nonallergic rhinitis supports conversion to allergic rhinitis. J llergy Clin Immunol, 2009,123 : 1098-1102.
4Task force for the diagnosis and management of syncope, Europe- an Society of Cardiology (ESC), European Heart Rhythm Associ ation (EHRA), et al. Guidelines for the diagnosis and manage- ment of syncope ( version 2(109 )[J]. Enr Heart J, 2009,30 ( 21 ) : 2631-2671.
5Reybrouck T, Heidbuchel H, Van De Werf, et al. Long-term follow-up results of tilt training therapy in patients with recurrent neurocardiogenic syncope[J]. Pacing Clin Electrophysiol, 2002,25 (10) : 1441-1446.
6Vyas A, Swaminathan PD, Zimmerman MB, et al. Are treat-merits for vasovagal syncope ef{eetive? A meta-analysis[J]. Int J CardioI,2013,167(5) :1906- 1911.
7Gills AM, Russo AM, Ellenbogen KA, et al. HRS/ACCF expert consensus statement on pacemaker device and mode selection[J]. Heart Rhythm,2012,9(8) :1344-1365.
8Romme JJ, Reitsma JB, Black CN, et al. Drugs and pacemakers for vasovagal, carotid sinus and situational syncope[J]. Cochrane Database Syst Rev,2011(10) :Cd004194.
9Ammirati F, Colivicchi F, Toscano S, et al. DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope[J]. Pacing Clin Electro- physiol,1998,21(11 Pt 2) :2178-2181.
10Flammang D, Antiel M, Church T, et al. Is a pacemaker indica- ted for vasovagal patients with severe cardioinhibitory reflex as identified by the ATP test? A preliminary randomized trial[J]. Europace,1999,1 (2) :140-145.
